AMBULATORY BLOOD-PRESSURE MEASUREMENT IN TYPE-2 DIABETIC-PATIENTS - METHODOLOGICAL ASPECTS

被引:24
作者
HANSEN, KW
SCHMITZ, A
PEDERSEN, MM
机构
[1] Medical Department M, Aarhus Kommunehospital
关键词
TYPE-2; DIABETES; BLOOD PRESSURE; AMBULATORY BLOOD PRESSURE; MEASUREMENT REPRODUCIBILITY;
D O I
10.1111/j.1464-5491.1991.tb01653.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ambulatory blood pressure was measured over 24 h on two occasions in 29 Type 2 diabetic patients age 65 (range 52-74) years, and the reproducibility compared with that of ordinary clinic measurements recorded by Hawskley's random zero sphygmomanometer. The variability of the difference between blood pressure measurements on the two occasions was twice as large for clinic measurement as for ambulatory measurement (2p < 0.01). If applied to clinical trials this would allow a fourfold reduction of patient numbers without losing test power. In the group of patients treated with antihypertensive medication (n = 16) the spontaneous decline in blood pressure after leaving the hospital proved to be most prominent in those patients with the highest clinic blood pressure, a phenomenon with importance for the management of hypertension. The individual difference between clinic measurements and ambulatory day-time measurements from the same day was unpredictable. Ambulatory blood pressure measurement in the outpatient clinic may be a practicable approach for optimizing antihypertensive treatment in Type 2 diabetic patients.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 42 条
  • [1] Standl E., Stiegler H., Roth R., Schulz K., Lehmacher W., On the impact of hypertension on the prognosis of NIDDM, results of the Schwabing GP‐program, Diabete Metab, 15, pp. 352-358, (1989)
  • [2] Uusitupa M., Sutonen O., Aro A., Pyorala K., Prevalence of coronary heart disease, left ventricular failure and hypertension in middle‐aged, newly diagnosed Type 2 (non‐insulin‐dependent) diabetic subjects, Diabetologia, 28, pp. 22-27, (1985)
  • [3] Reaven GM, Non‐insulin‐dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis, Metabolism, 36, pp. 1-8, (1987)
  • [4] Kannel WB, McGee DL, Diabetes and cardiovascular disease. The Framingham Study, JAMA, 241, pp. 2035-2038, (1979)
  • [5] Fuller JH, Shipley MJ, Rose G., Jarrett RJ, Keen H., Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study, Br Med J, 287, pp. 867-870, (1983)
  • [6] Cruickshank JM, Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction, Br Med J, 297, pp. 1227-1230, (1988)
  • [7] Zanchetti A., Amery A., Berglund G., Et al., Clinical Round Table. How much should blood pressure be lowered? The problem of the J‐shaped curve, J Hypertension, 7, (1989)
  • [8] Rose GA, Holland WW, Crowley EA, A sphygmomanometer for epidemiologists, Lancet, 1, pp. 296-300, (1964)
  • [9] Bruce NG, Shaper G., Walker M., Wannamethee G., Observer bias in blood pressure studies, J Hypertens, 6, pp. 375-380, (1988)
  • [10] Weber MA, Whole‐day blood pressure, Hypertension, 11, pp. 288-298, (1988)